Bisphenol A promotes human prostate stem-progenitor cell self-renewal and increases in vivo carcinogenesis in human prostate epithelium

Endocrinology

Volumn 155, Issue 3, 2014, Pages 805-817

  Prins, Gail S ^a,b   Hu, Wen Yang ^a   Shi, Guang Bin ^a   Hu, Dan Ping ^a   Majumdar, Shyama ^a   Li, Guannan ^b   Huang, Ke ^b   Nelles, Jason L ^a   Ho, Shuk Mei ^c   Walker, Cheryl Lyn ^d   Kajdacsy Balla, Andre ^a,b   Van Breemen, Richard B ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; TESTOSTERONE;

AGED; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CANCER RISK; CARCINOGENESIS; CELL CULTURE; CELL FUNCTION; CELL MEMBRANE; CELL RENEWAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY GRAFT; LOW DRUG DOSE; MALE; MESENCHYMAL STEM CELL; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RAT; SERUM; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; BENZHYDRYL COMPOUNDS; CARCINOGENESIS; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITHELIUM; ESTROGENS; ESTROGENS, NON-STEROIDAL; FLOW CYTOMETRY; HUMANS; MALE; MICE; MICE, NUDE; PHENOLS; PROSTATE; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELLS; TANDEM MASS SPECTROMETRY; TIME FACTORS; YOUNG ADULT;

EID: 84896829608     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1955     Document Type: Article

References (62)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.
2. Bosland MC, Mahmoud AM. Hormones and prostate carcinogenesis: androgens and estrogens. J Carcinog. 2011;10:33.
3. Prins GS, Putz O. Molecular signaling pathways that regulate prostate gland development. Differentiation. 2008;76:641-659. (Pubitemid 352032742)
4. Adams JY, Leav I, Lau KM, Ho SM, Pflueger SM. Expression of estrogen receptor β in the fetal, neonatal, and prepubertal human prostate. Prostate. 2002;52:69-81. (Pubitemid 34553193)
5. Henderson BE, Ross RK, Pike MC. Toward the primary prevention of cancer. Science. 1991;254:1131-1138. (Pubitemid 21917437)
6. Ekbom A. Growing evidence that several human cancers may originate in utero. Semin Cancer Biol. 1998;8:237-244.
7. Margel D, Fleshner NE. Oral contraceptive use is associated with prostate cancer: an ecological study. BMJ Open. 2011;1:e000311.
8. Rahman AA, Lophatananon A, Stewart-Brown S, et al. Hand pattern indicates prostate cancer risk. Br J Cancer. 2011;104:175-177.
9. Barker DJ, Osmond C, Thornburg KL, Kajantie E, Eriksson JG. A possible link between the pubertal growth of girls and prostate cancer in their sons. Am J Hum Biol. 2012;24:406-410.
10. Santti R, Newbold RR, Mäkelä S, Pylkkänen L, McLachlan JA. Developmental estrogenization and prostatic neoplasia. Prostate. 1994;24:67-78. (Pubitemid 24073105)
11. Prins GS, Birch L, Couse JF, Choi I, Katzenellenbogen B, Korach KS. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor α: studies with αERKO and βERKO mice. Cancer Res. 2001;61:6089-6097. (Pubitemid 32762544)
12. Prins GS, Huang L, Birch L, Pu Y. The role of estrogens in normal and abnormal development of the prostate gland. Ann NY Acad Sci. 2006;1089:1-13. (Pubitemid 47092064)
13. Prins GS, Ho SM. Early life estrogens and prostate cancer in an animal model. J Dev Origins Health Dis. 2010;1:365-370.
14. Wetherill YB, Akingbemi BT, Kanno J, et al. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol. 2007;24:178-198. (Pubitemid 47385095)
15. Biedermann S, Tschudin P, Grob K. Transfer of bisphenol A from thermal printer paper to the skin. Anal Bioanal Chem. 2010;398:571-576.
16. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect. 2010;118:1055-1070.
17. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect. 2008;116:39-44.
18. Nahar MS, Liao C, Kannan K, Dolinoy DC. Fetal liver bisphenol A concentrations and biotransformation gene expression reveal variable exposure and altered capacity for metabolism in humans. J Biochem Mol Toxicol. 2013;27:116-123.
19. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007;24:139-177. (Pubitemid 47385100)
20. Padmanabhan V, Siefert K, Ransom S, et al. Maternal bisphenol-A levels at delivery: a looming problem? J Perinatol. 2008;28:258-263. (Pubitemid 351493659)
21. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Cien Saude Colet. 2012;17:407-434.
22. Gerona RR, Woodruff TJ, Dickenson CA, et al. Bisphenol-A (BPA), BPA glucuronide, and BPA sulfate in midgestation umbilical cord serum in a northern and central California population. Environ Sci Technol. 2013;47:12477-12485
23. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 2006;66:5624-5632. (Pubitemid 43927114)
24. Prins GS, Ye SH, Birch L, Ho SM, Kannan K. Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats. Reprod Toxicol. 2011;31:1-9.
25. Tang WY, Morey LM, Cheung YY, Birch L, Prins GS, Ho SM. Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout life. Endocrinology. 2012;153:42-55.
26. Prins GS. Developmental estrogenization of the prostate gland. In: Naz RK, ed. Prostate: Basic and Clinical Aspects. Boca Raton, FL: CRC Press; 1997:247-265.
27. Habermann H, Chang WY, Birch L, Mehta P, Prins GS. Developmental exposure to estrogens alters epithelial cell adhesion and gap junction proteins in the adult rat prostate. Endocrinology. 2001; 142:359-369. (Pubitemid 32183697)
28. Hu WY, Shi GB, Lam HM, et al. Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells. Endocrinology. 2011;152:2150-2163.
29. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci USA. 2008;105:20882-20887.
30. Goldstein AS, Drake JM, Burnes DL, et al. Purification and direct transformation of epithelial progenitor cells from primary human prostate. Nat Protoc. 2011;6:656-667.
31. Brown MD, Gilmore PE, Hart CA, et al. Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. Prostate. 2007;67:1384-1396. (Pubitemid 47435786)
32. Hu WY, Shi GB, Hu DP, Nelles JL, Prins GS. Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk. Mol Cell Endocrinol. 2012;354:63-73.
33. Greathouse KL, Bredfeldt T, Everitt JI, et al. Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis. Mol Cancer Res. 2012;10:546-557.
34. Ince BA, Montano MM, Katzenellenbogen BS. Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3′,5′- monophosphate and ligands including antiestrogens. Mol Endocrinol. 1994;8:1397-1406.
35. Soto AM, Lin TM, Justicia H, Silvia RM, Sonnenschein C. An "in culture" bioassay to assess the estrogenicity of xenobiotics. In: Colborn T, Clement C, eds. Chemically Induced Alterations in Sexual Development: The Wildlife/Human Connection. Princeton, NJ: Princeton Scientific Publishing; 1992:295-309. (Pubitemid 24193012)
36. Taylor JA, Vom Saal FS, Welshons WV, et al. Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ Health Perspect. 2011;119:422-430.
37. Levin ER. Minireview: Extranuclear steroid receptors: roles in modulation of cell functions. Mol Endocrinol. 2011;25:377-384.
38. Smith S, Neaves W, Teitelbaum S. Adult versus embryonic stem cells: treatments. Science. 2007;316:1422-1423; author reply 1422-1423.
39. Shelby M. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Bisphenol A. Bethesda, MD: National Institutes of Health; 2008. NIH publication 08-5994.
40. Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol. 2013;42:132-155.
41. Vandenberg LN, Maffini MV, Wadia PR, et al. Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology. 2007;148:116-127. (Pubitemid 46021444)
42. Walker CL, Ho SM. Developmental reprogramming of cancer susceptibility. Nat Rev Cancer. 2012;12:479-486.
43. Okada M, Makino A, Nakajima M, Okuyama S, Furukawa S, Furukawa Y. Estrogen stimulates proliferation and differentiation of neural stem/progenitor cells through different signal transduction pathways. Int J Mol Sci. 2010;11:4114-4123.
44. Chamorro-García R, Kirchner S, Li X, et al. Bisphenol A diglycidyl ether induces adipogenic differentiation of multipotent stromal stem cells through a peroxisome proliferator-activated receptor gamma-independent mechanism. Environ Health Perspect. 2012;120:984-989.
45. Baik I, Devito WJ, Ballen K, et al. Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer. Cancer Res. 2005;65:358-363. (Pubitemid 40070829)
46. Yang L, Luo L, Ji W, et al. Effect of low dose bisphenol A on the early differentiation of human embryonic stem cells into mammary epithelial cells. Toxicol Lett. 2013;218:187-193.
47. Sui Y, Ai N, Park SH, et al. Bisphenol A and its analogues activate human pregnane X receptor. Environ Health Perspect. 2012;120:399-405.
48. Delfosse V, Grimaldi M, Pons JL, et al. Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes. Proc Natl Acad Sci USA. 2012;109:14930-14935.
49. Watson CS, Alyea RA, Jeng YJ, Kochukov MY. Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues. Mol Cell Endocrinol. 2007;274:1-7. (Pubitemid 47126682)
50. Le Romancer M, Poulard C, Cohen P, Sentis S, Renoir JM, Corbo L. Cracking the estrogen receptor's posttranslational code in breast tumors. Endocr Rev. 2011;32:597-622.
51. Cha TL, Zhou BP, Xia W, et al. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science. 2005;310:306-310. (Pubitemid 41457195)
52. Belcher SM, Chen Y, Yan S, Wang HS. Rapid estrogen receptor-mediated mechanisms determine the sexually dimorphic sensitivity of ventricular myocytes to 17β-estradiol and the environmental endocrine disruptor bisphenol A. Endocrinology. 2012;153:712-720.
53. Vinas R, Watson CS. Mixtures of xenoestrogens disrupt estradiol-induced non-genomic signaling and downstream functions in pituitary cells. Environ Health. 2013;12:26.
54. Soriano S, Alonso-Magdalena P, Garcia-Arevalo M, et al. A Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor β. PLoS One. 2012;7:e31109.
55. Xu X, Ye Y, Li T, et al. Bisphenol-A rapidly promotes dynamic changes in hippocampal dendritic morphology through estrogen receptor-mediated pathway by concomitant phosphorylation of NMDA receptor subunit NR2B. Toxicol Appl Pharmacol. 2010; 249:188-196.
56. Pennie WD, Aldridge TC, Brooks AN. Differential activation by xenoestrogens of ERα and ERβ when linked to different response elements. J Endocrinol. 1998;158:R11-R14. (Pubitemid 28407555)
57. Li Y, Burns KA, Arao Y, Luh CJ, Korach KS. Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone through estrogen receptor α and β in vitro. Environ Health Perspect. 2012;120:1029-1035.
58. Birnbaum LS, Fenton SE. Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect. 2003;111:389-394. (Pubitemid 36546511)
59. Dekant W, Völkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol. 2008;228:114-134.
60. Schönfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect. 2002;110:A703-A707. (Pubitemid 35363745)
61. Fénichel P, Déchaux H, Harthe C, et al. Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes. Hum Reprod. 2012;27:983-990.
62. Edlow AG, Chen M, Smith NA, Lu C, McElrath TF. Fetal bisphenol A exposure: concentration of conjugated and unconjugated bisphenol A in amniotic fluid in the second and third trimesters. Reprod Toxicol. 2012;34:1-7.